(Q54198879)
Statements
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. (English)
W H Wilson
S Bates
A Fojo
J O'Shaughnessy
S L Berg
G Bryant
R E Wittes
S M Steinberg
B R Goldspiel
J Herdt
1 August 1994
12
8
1621-1629